Graduate research associate Sanjana Rajan shares why her work to label and track cells before and after chemotherapy is the next step to preventing tumor relapse.
The latest in the body of antimicrobial peptide research suggests RNase7 may be a useful prognostic marker and potential therapeutic option for UTIs.
As he retires, the CEO of Nationwide Children's Hospital reflects on the less-obvious effects of scientific discovery.
Rachael Hardison, PhD, shares recently published work from her graduate studies in the Mason and Justice Labs in The Research Institute at Nationwide Children’s.
An understanding of how bacteria adapt to microenvironments in the body could help clear persistent ear infections.
A protein that triggers an imbalance of mucous and ciliated cells in patients with chronic lung disease could be a target for treatments to restore airways.
The Research Institute at Nationwide Children’s Hospital is the home to a current Good Manufacturing Practices (cGMP) Clinical Manufacturing Facility (CMF) that operates according to FDA cGMP Guidelines to ensure the safety of manufactured biologic products.
